ArticleMedical oncology (Northwood, London, England)2025
The influence of maximal androgen blockade and radical prostatectomy on urinary extracellular vesicle miRNA expression.
Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Urinary Biomarkers for Radiation Cystitis: Current Insights and Future Directions.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Prostate cancer (PC) is one of the most common oncological diseases. Maximal androgen blockade (MAB) is used at different stages of treatment, including prior to radical prostatectomy (RP). The data on the expression of extracellular miRNAs involved in carcinogenesis before and after MAB/RP's are demanded for the selection of miRNAs markers for the diagnostics of PC and the effectiveness of PC treatment as well as insight of these miRNAs and their regulated genes involvement in oncogenesis. The aim of this study was to screen 13 miRNAs associated with PC from urine extracellular vesicles (EVs) of healthy donors (HD) and PC patients before and after MAB, RP, and MAB followed RP in looking for correlations with PC and PC treatment/clinical characteristics followed by identification of the most distinctive miRNA signatures as set of markers for the future extensive verification. Urine samples were collected from HD and PC patients, both those who had undergone neoadjuvant therapy and those who had not, prior to radical prostatectomy (RP) and one-week post-surgery. EVs were isolated using the aggregation-precipitation method, and miRNAs within EVs were extracted using glass fiber sorbents. The quantification of the 13 miRNAs was performed using reverse transcription TaqMan PCR (RT-PCR), with subsequent paired ratio-based normalization followed by the selection of miRNA ratios differentially expressed between the comparison groups from the set of all miRNA pairs. A comparative analysis of the relative expression of miRNAs in the urine of PC patients versus HD was conducted, revealing 49 ratios of differentially expressed miRNAs influenced by therapy. The study identified specific miRNAs with significant expression changes due to various treatments: influence of MAB, RP, and RP in patients after neoadjuvant MAB, as well as under the influence of MAB followed by RP. The relative expression of the extracellular miRNAs studied was influenced by the type and combination of various PC treatments, which indicates the prospects of specific miRNA predictors of PC treatment effectiveness.
Indexed as
Identifiers
40293608What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.